Pediatrix Medical Group - MD Stock Forecast, Price & News

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. BMO Capital Markets reduced their price target on shares of Pediatrix Medical Group from $25.00 to $23.00 and set a "market perform" rating on the stock in a research report on Wednesday. StockNews.com lowered shares of Pediatrix Medical Group from a "buy" rating to a "hold" rating in a report on Monday, May 2nd. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Pediatrix Medical Group from $24.00 to $16.00 in a report on Tuesday, May 10th. Mizuho dropped their price objective on shares of Pediatrix Medical Group from $28.00 to $23.00 in a report on Monday, May 2nd. Finally, TheStreet lowered shares of Pediatrix Medical Group from a "b-" rating to a "c+" rating in a report on Wednesday, April 13th. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $25.17.

Pediatrix Medical Group Stock Up 1.9 %

MD Stock traded up $0.39 during midday trading on Wednesday, hitting $21.04. The company's stock had a trading volume of 670,186 shares, compared to its average volume of 619,267. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.39 and a quick ratio of 1.39. Pediatrix Medical Group has a twelve month low of $17.17 and a twelve month high of $35.67. The company's fifty day moving average price is $21.37 and its 200 day moving average price is $22.04. The stock has a market capitalization of $1.84 billion, a P/E ratio of 21.47, a PEG ratio of 1.22 and a beta of 1.84.

Pediatrix Medical Group (NYSE:MD - Get Rating) last issued its quarterly earnings results on Thursday, August 4th. The company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.04. Pediatrix Medical Group had a net margin of 4.30% and a return on equity of 16.15%. The firm had revenue of $486.00 million for the quarter, compared to analyst estimates of $491.54 million. During the same period in the previous year, the business earned $0.36 EPS. The company's revenue was up 2.7% compared to the same quarter last year. As a group, equities research analysts predict that Pediatrix Medical Group will post 1.73 EPS for the current year.